Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Study Information
Alliance Study ID: A221801
NCT Study ID (ClinicalTrials.gov): NCT05379153
Alliance Committee: Cancer Control
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Maryam Lustberg, MD, MPH
Status: RECRUITING
Study Description
This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be commonly experienced with normal aging, with menopause, or come about from medications used to treat breast cancer such as chemotherapy or endocrine therapies like tamoxifen or aromatase inhibitors. Vaginal fractional CO2 laser therapy may help reduce vaginal dryness.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Locations (2)
Trinity Health IHA – Obstetrics and Gynecology West Arbor
Ann Arbor, Michigan 48103
United States
Ohio State University Comprehensive Cancer Center
Columbus, Ohio 43210
United States
Data Sources & Contacts
Full trial details
For more Information